ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 89 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $95,665,000 | -89.8% | 13,455 | -87.8% | 0.00% | -100.0% |
| Q4 2018 | $940,775,000 | -81.8% | 110,161 | -57.4% | 0.00% | -75.0% |
| Q3 2018 | $5,171,025,000 | -3.7% | 258,293 | +24.2% | 0.00% | 0.0% |
| Q2 2018 | $5,371,968,000 | +19.9% | 207,974 | +10.9% | 0.00% | 0.0% |
| Q1 2018 | $4,480,748,000 | -32.9% | 187,479 | -4.9% | 0.00% | -33.3% |
| Q4 2017 | $6,679,651,000 | +2578915.8% | 197,098 | +1051.9% | 0.01% | – |
| Q2 2016 | $259,000 | -38.8% | 17,110 | -41.6% | 0.00% | – |
| Q1 2016 | $423,000 | -7.6% | 29,281 | +81.1% | 0.00% | -100.0% |
| Q4 2015 | $458,000 | +31.2% | 16,166 | -22.4% | 0.00% | – |
| Q3 2015 | $349,000 | -40.5% | 20,840 | -6.9% | 0.00% | -100.0% |
| Q2 2015 | $587,000 | – | 22,373 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,423,578 | $8,826,000 | 6.08% |
| Healthcare Value Capital, LLC | 200,000 | $1,240,000 | 2.33% |
| ARMISTICE CAPITAL, LLC | 2,700,000 | $16,740,000 | 1.06% |
| DELTEC ASSET MANAGEMENT LLC | 550,836 | $3,415,000 | 0.75% |
| Broadfin Capital, LLC | 441,088 | $2,735,000 | 0.60% |
| Kerrisdale Advisers, LLC | 229,347 | $1,422,000 | 0.51% |
| Worth Venture Partners, LLC | 87,908 | $545,000 | 0.30% |
| Mosaic Family Wealth, LLC | 91,314 | $566,000 | 0.24% |
| EMERALD ADVISERS, LLC | 700,176 | $4,341,000 | 0.17% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 616,664 | $3,823,000 | 0.15% |